Cell Therapy Limited

Active06970743 Private limited company
Incorporated
23 July 2009 (17 years)
Industry
Other research and experimental development on natural sciences and engineering (72190)
Directors
Ajan Reginald
Controlled by
Accounts type
Small
Region
West Midlands
Address
Celixir House Stratford-Upon-Avon Business And Technology Park
Innovation Way
Stratford-Upon-Avon
CV37 7GZ

Filing status

Accounts due
31 December 2026
Last accounts
31 March 2025
Conf. stmt due
13 March 2027
Last conf. stmt
27 February 2026

Officers 2 active

Officer details are public data from the Companies House register.

Reginald, Ajan
Director · Appointed 26 July 2021
British
Born February 1972 (54)
Corporate Director · Appointed 15 January 2019
Officer history (19 former)
26 July 2021
Appointed Reginald, Ajan as Director
9 April 2021
Resigned Reginald, Trevor Ajan as Director
9 April 2021
Resigned Evans, Martin John, Sir as Director
16 March 2020
Resigned Preston, David William as Secretary
15 January 2019
Resigned Preston, David William as Director
15 January 2019
Resigned Ribbons, Duncan Mark Powell as Director
15 January 2019
Resigned Scott, Nigel James, Dr as Director
15 January 2019
Resigned Sultan, Sabena, Dr as Director
15 January 2019
Resigned Chapman, Lee Phillip, Dr as Director
15 January 2019
Appointed Cardiogeni Plc as Corporate Director
7 January 2019
Resigned Sheikh, Mubasher as Director
17 July 2018
Resigned Bird, Anthony Patrick Michael as Director
26 January 2018
Resigned Jones, Digby Marritt, Lord as Director
31 December 2017
Resigned Beards, Mark Granville as Director
17 May 2017
Resigned Morgan, Hywel Rhodri, Rt Hon as Director
30 April 2017
Resigned Hughes, Mark Leonard William as Director
12 April 2017
Appointed Scott, Nigel James, Dr as Director
12 April 2017
Resigned Disley, Darrin Matthew, Dr as Director
12 April 2017
Resigned Hurvitz, Chaim as Director
12 April 2017
Appointed Ribbons, Duncan Mark Powell as Director
12 April 2017
Appointed Chapman, Lee Phillip, Dr as Director
16 September 2016
Resigned Granata, Francesco, Dr as Director
1 February 2016
Appointed Hurvitz, Chaim as Director
23 September 2015
Appointed Disley, Darrin Matthew, Dr as Director
23 September 2015
Appointed Granata, Francesco, Dr as Director
22 May 2015
Appointed Beards, Mark Granville as Director
20 January 2015
Appointed Sultan, Sabena, Dr as Director
20 January 2015
Appointed Preston, David William as Director
20 January 2015
Appointed Preston, David William as Secretary
20 January 2015
Appointed Hughes, Mark Leonard William as Director
23 November 2014
Appointed Jones, Digby Marritt, Lord as Director
23 November 2014
Appointed Bird, Anthony Patrick Michael as Director
1 January 2013
Appointed Morgan, Hywel Rhodri, Rt Hon as Director
1 August 2012
Appointed Sheikh, Mubasher as Director
1 June 2012
Appointed Reginald, Trevor Ajan as Director
14 November 2011
Resigned Reginald, Ajan, Dr as Secretary
14 November 2011
Resigned Reginald, Ajan Trevor, Dr as Director
23 July 2009
Appointed Reginald, Ajan, Dr as Secretary
23 July 2009
Appointed Reginald, Ajan Trevor, Dr as Director
23 July 2009
Appointed Evans, Martin John, Sir as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 6 January 2025
Has significant influence or control
Has significant influence or control (as a firm)
Public Limited Company
Reg. no. 10541091
Former controllers (4)
6 January 2025
Ceased Celixir Limited — Owns 75–100% of shares
12 April 2017
Ceased Martin John Evans — Owns 25–50% of shares
12 April 2017
Ceased Mubasher Shiekh — Owns 25–50% of shares
12 April 2017
Ceased Trevor Ajan Reginald — Owns 25–50% of shares

Group structure 5 companies

Ownership group derived from the Companies House PSC register

Celixir Limited Has significant influence or control
Cell Therapy Limited This company Has significant influence or control
Desktop Genetics Ltd Has significant influence or control
Sirna Limited Has significant influence or control

Financials

Balance sheet as at 31 March 2025 · small accounts

Net Assets
(£3,779,356)
Cash
£29,530
Employees
2
Debt Ratio
447%

Trend

Net Assets
(£15.0M) (£10.0M) (£5.0M) £0 2022 2023 2024 2025 (£10,092,009) (£10,178,342) (£10,682,911) (£3,779,356)
Balance sheet detail
2025202420232022
Fixed Assets£613,154£678,922£761,929£747,034
Current Assets£476,180£607,445£1,543,338£1,584,959
Debtors£446,650£454,355£1,258,180£1,321,901
Cash£29,530£153,090£285,158£263,058
Creditors (< 1 year)£4,843,944£4,578,526£4,090,669
Creditors (> 1 year)£43,200£7,110,334£7,905,083£8,333,333
Net Current Assets(£4,324,310)(£4,236,499)(£3,035,188)(£2,505,710)
Net Assets(£3,779,356)(£10,682,911)(£10,178,342)(£10,092,009)
Shareholder Funds(£10,682,911)(£10,178,342)(£10,092,009)

Filings

Filing history not loaded yet. See it on Companies House

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?